Study of Mental Fatigue in Polio Survivors

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2007 by Uniformed Services University of the Health Sciences.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Uniformed Services University of the Health Sciences
ClinicalTrials.gov Identifier:
NCT00487487
First received: June 14, 2007
Last updated: June 15, 2007
Last verified: March 2007
  Purpose

Post-Poliomyelitis Syndrome (PPS) is the term describing the new problems affecting polio survivors many years after recovery from paralytic polio. Among the symptoms, fatigue is one of the most frequent and debilitating. In addition to physical incapacitation, the fatigue of PPS also affects mental function. The term “brain fatigue” is usually used by patients to express problems on the areas of attention, concentration, memory and clear thinking. Unfortunately, little is known about cognitive fatigue of PPS patients. This study is meant to examine if mental impairment is present in PPS patients and, if so, how it interferes on the self-function of patients. Patients will undergo an interview, clinical and neurological evaluation, and a battery of screening laboratory tests to make sure they are eligible for the study. Patients who qualify will undergo neuropsychometric tests in order to assay performance in the main areas of cognitive functioning. Through this organized approach we expect to be able to determine if mental fatigue is a significant problem affecting polio survivors, what areas are most affected, and how it may interfere with daily living.


Condition
Post-Poliomyelitis Syndrome

Study Type: Observational
Study Design: Allocation: Random Sample
Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by Uniformed Services University of the Health Sciences:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years of age or older
  • Be a survivor of poliomyelitis
  • Willing to attend two clinic visits for completion of screening procedures and required tests

Exclusion Criteria:

  • Suffer from medical conditions that can interfere with cognitive function, including stroke, traumatic brain injury, dementia (progressive memory loss), severe depression, psychosis or other psychiatric disorders, etc.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00487487

Contacts
Contact: Sandra Maxwell, RN 301-9840400 smaxwell@usuhs.edu

Locations
United States, Maryland
Postpolio Syndrome Outpatient Research Office Recruiting
Rockville, Maryland, United States, 20852
Contact: Sandra Maxwell, RN    301-984-0400    smaxwell@usuhs.edu   
Sub-Investigator: Olavo M Vasconcelos, MD         
Sponsors and Collaborators
Uniformed Services University of the Health Sciences
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00487487     History of Changes
Other Study ID Numbers: USUHS-G192EI
Study First Received: June 14, 2007
Last Updated: June 15, 2007
Health Authority: United States: Federal Government

Keywords provided by Uniformed Services University of the Health Sciences:
Candidates for this study are survivors of paralytic poliomyelitis

Additional relevant MeSH terms:
Poliomyelitis
Postpoliomyelitis Syndrome
Myelitis
Central Nervous System Viral Diseases
Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Central Nervous System Infections
Central Nervous System Diseases
Nervous System Diseases
Spinal Cord Diseases
Neuromuscular Diseases
Muscular Disorders, Atrophic
Muscular Diseases
Musculoskeletal Diseases
Neurodegenerative Diseases

ClinicalTrials.gov processed this record on July 22, 2014